Centerpoint Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Centerpoint Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$680.49 - $826.97 $1,360 - $1,653	2 Added 25.0%	10 $8,000
Q4 2021 Jan 14, 2022	BUY	$543.48 - $670.97 $4,347 - $5,367	8 New	8 $5,000
Q3 2020 Oct 13, 2020	SELL	$544.75 - $658.21 $13,074 - $15,797	-24 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$493.32 - $643.92 $11,839 - $15,454	24 New	24 $15,000
Q1 2019 Apr 25, 2019	SELL	$372.08 - $439.57 $20,464 - $24,176	-55 Closed	0 $0
Q4 2017 Mar 14, 2018	BUY	$358.63 - $469.95 $19,724 - $25,847	55	55 $21,000

1,516

82.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Centerpoint Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Centerpoint Advisors, LLC with notifications on news.